Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 93 | 40 | 142 | 297 | 276 |
| Cost of Goods | 55 | 30 | 89 | 147 | 155 |
| Gross Profit | 39 | 11 | 53 | 150 | 121 |
| Operating Expenses | 6,967 | 7,083 | 4,273 | 4,762 | 6,935 |
| Operating Income | -6,874 | -7,043 | -4,131 | -4,465 | -6,659 |
| Interest Expense | 0 | 0 | 711 | 1,391 | 853 |
| Other Income | 34 | -324 | 407 | -667 | 2,516 |
| Pre-tax Income | -6,840 | -7,367 | -4,435 | -6,523 | -4,995 |
| Net Income Continuous | -6,840 | -7,367 | -4,435 | -6,523 | -4,995 |
| Net Income | $-6,840 | $-7,367 | $-4,435 | $-6,523 | $-4,995 |
| EPS Basic Total Ops | -232,139.80 | -1.27 | 74.34 | -11.77 | -33.96 |
| EPS Basic Continuous Ops | -232,092.90 | -1.27 | 74.34 | -11.77 | -33.96 |
| EPS Diluted Total Ops | -232,139.80 | -1.27 | 74.34 | -11.77 | -33.96 |
| EPS Diluted Continuous Ops | -232,092.90 | -1.27 | 74.34 | -11.77 | -33.96 |
| EBITDA(a) | $-6,835 | $-7,014 | $-3,860 | $-3,833 | $-6,440 |